1. Influence of tumour burden on trastuzumab pharmacokinetics in HER2 positive non‐metastatic breast cancer. (7th March 2016) Authors: Bernadou, Guillemette; Campone, Mario; Merlin, Jean‐Louis; Gouilleux‐Gruart, Valérie; Bachelot, Thomas; Lokiec, François; Rezai, Keyvan; Arnedos, Monica; Diéras, Véronique; Jimenez, Marta; Paintaud, Gilles; Ternant, David Journal: British journal of clinical pharmacology Issue: Volume 81:Number 5(2016:May) Page Start: 941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Single radio UHPLC analysis for the quality control of technetium-99m radiolabelled radiopharmaceuticals. (October 2021) Authors: Schmitt, Camille; Fouque, Julien; Huguet, Samuel; Da Costa Branquinho, Emilie; Blondeel, Sandy; Rezai, Keyvan; Madar, Olivier Journal: Applied radiation and isotopes Issue: Volume 176(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial). (November 2021) Authors: Campone, Mario; Bachelot, Thomas; Treilleux, Isabelle; Pistilli, Barbara; Salleron, Julia; Seegers, Valérie; Arnedos, Monica; Loussouarn, Delphine; Wang, Qing; Vanlemmens, Laurence; Jimenez, Marta; Rios, Maria; Diéras, Véronique; Leroux, Agnès; Paintaud, Gilles; Rezai, Keyvan; André, Fabrice; Lio... Journal: European journal of cancer Issue: Volume 158(2021) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients. (December 2021) Authors: Vicier, Cecile; Sfumato, Patrick; Isambert, Nicolas; Dalenc, Florence; Robert, Marie; Levy, Christelle; Rezai, Keyvan; Provansal, Magali; Adélaïde, José; Garnier, Séverine; Guille, Arnaud; Carbuccia, Nadine; Popovici, Cornel; Charafe-Jauffret, Emmanuelle; Chaffanet, Max; Birnbaum, Daniel; Pakrado... Journal: European journal of cancer Issue: Volume 159(2021) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial. Issue 32 (10th November 2021) Authors: Bautista, Francisco; Paoletti, Xavier; Rubino, Jonathan; Brard, Caroline; Rezai, Keyvan; Nebchi, Souad; Andre, Nicolas; Aerts, Isabelle; De Carli, Emilie; van Eijkelenburg, Natasha; Thebaud, Estelle; Corradini, Nadege; Defachelles, Anne-Sophie; Ducassou, Stephane; Morscher, Raphael J.; Vassal, Gi... Journal: Journal of clinical oncology Issue: Volume 39:Issue 32(2021) Page Start: 3546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models. Issue 9 (30th July 2016) Authors: Berenguer‐Daizé, Caroline; Astorgues‐Xerri, Lucile; Odore, Elodie; Cayol, Mylène; Cvitkovic, Esteban; Noel, Kay; Bekradda, Mohamed; MacKenzie, Sarah; Rezai, Keyvan; Lokiec, François; Riveiro, Maria E.; Ouafik, L'Houcine Journal: International journal of cancer Issue: Volume 139:Issue 9(2016:Nov. 01) Page Start: 2047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models. Issue 12 (15th October 2019) Authors: Astorgues-Xerri, Lucile; Vázquez, Ramiro; Odore, Elodie; Rezai, Keyvan; Kahatt, Carmen; Mackenzie, Sarah; Bekradda, Mohamed; Coudé, Marie-Magdelaine; Dombret, Herve; Gardin, Claude; Lokiec, Francois; Raymond, Eric; Noel, Kay; Cvitkovic, Esteban; Herait, Patrice; Bertoni, Francesco; Riveiro, María E. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 12(2019) Page Start: 3067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. (November 2017) Authors: Guerin, Mathilde; Rezai, Keyvan; Isambert, Nicolas; Campone, Mario; Autret, Aurélie; Pakradouni, Jihane; Provansal, Magali; Camerlo, Jacques; Sabatier, Renaud; Bertucci, François; Charafe-Jauffret, Emmanuelle; Hervieu, Alice; Extra, Jean-Marc; Viens, Patrice; Lokiec, François; Boher, Jean-Marie; ... Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. Issue 4 (April 2016) Authors: Amorim, Sandy; Stathis, Anastasios; Gleeson, Mary; Iyengar, Sunil; Magarotto, Valeria; Leleu, Xavier; Morschhauser, Franck; Karlin, Lionel; Broussais, Florence; Rezai, Keyvan; Herait, Patrice; Kahatt, Carmen; Lokiec, François; Salles, Gilles; Facon, Thierry; Palumbo, Antonio; Cunningham, David; Z... Journal: Lancet Issue: Volume 3:Issue 4(2016) Page Start: e196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study. Issue 4 (April 2016) Authors: Berthon, Céline; Raffoux, Emmanuel; Thomas, Xavier; Vey, Norbert; Gomez-Roca, Carlos; Yee, Karen; Taussig, David Christopher; Rezai, Keyvan; Roumier, Christophe; Herait, Patrice; Kahatt, Carmen; Quesnel, Bruno; Michallet, Mauricette; Recher, Christian; Lokiec, François; Preudhomme, Claude; Dombre... Journal: Lancet Issue: Volume 3:Issue 4(2016) Page Start: e186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗